<DOC>
	<DOCNO>NCT02300688</DOCNO>
	<brief_summary>After administration besifovir preparation different healthy subject , investigator evaluate equivalence bioavailability LB80331 .</brief_summary>
	<brief_title>Bioequivalence Study Compare Pharmacokinetics Besifovir Healthy Adult Volunteers</brief_title>
	<detailed_description>The purpose study evaluate equivalence bioavailability LB80331 preparation different . Following randomly allocate sequence group administer relevant test drug 1 time accord determined schedule Treatment A Treatment B period .</detailed_description>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<criteria>1 . Male whose age 19 year 55 year less full time screen test 2 . Subjects whose body mass index 19 kg/m2 27 kg/m2 less time screen test 3 . Subjects listen sufficient explanation purpose content Clinical Trial characteristic test drug spontaneously agree participate study write 4 . Subjects ability volition participate Clinical Trial entire period 1 . Subjects clinically significant disease medical history disease hepatobiliary , gastrointestinal , urinary , respiratory , cardiovascular system , musculoskeletal , endocrine system , neuropsychiatric disease , blood disease tumor 2 . Subjects hereditary problem galactose intolerance , Lapp lactase deficiency , glucosegalactose malabsorption 3 . Subjects medical history hypersensitivity drug ( aspirin , antibiotic ) allergic disease require treatment 4 . Subjects administer investigational product within past 60 day day random allocation 5 . Subjects donate whole blood within past 60 day day random allocation donate component blood within past 30 day day random allocation 6 . Subjects take drug need doctor 's prescription oriental herbal medicine within past 14 day day random allocation take overthecounter drug within past 7 day day random allocation ( Only , select subject accord decision investigator ) 7 . Subjects whose average drinking quantity per week exceeds alcohol 140g 8 . Subjects whose average smoking quantity exceed 20 cigarette subject stop smoke hospitalization 9 . Subjects whose average quantity intake grapefruit juice per day exceed 4 glass 10 . Subjects whose systolic blood pressure le 90 mmHg 140 mmHg diastolic pressure le 60 mmHg 100 mmHg time screen test 11 . Subjects whose AST , ALT , total bilirubin , Î³glutamyl transferasevalues blood exceed 1.5 time upper limit reference 12 . Subjects whose Creatine phosphokinase value blood exceed 2.5 time upper limit reference 13 . Subjects whose glomerular filtration rate calculate creatinine value blood le 60 mL/min . 14 . Subjects show negative reaction test hepatitis B , test hepatitis C , HIV test test syphilis 15 . Subjects show positive reaction urine drug screen test 16 . Subjects decide suitable participation Clinical Trial investigator reason</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>